ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 758539 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 758539; 2) Community: the network communities that were significantly associated with the response to NSC 758539; 3) Molecule: the relationships between components within communities and NSC 758539; 4) MDR: the compounds that were significantly associated with the NSC 758539.

NSC Compound Enrichment Correlation
NSC 107124 Camptothecin Derivative 0.0370731367697099 0.17449051
NSC 109836 Null 0.0370731367697099 0.21231347
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0370731367697099 0.31902438
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0370731367697099 0.16889697
NSC 129518 Cyclopyrethrosin 0.0370731367697099 -0.033628012
NSC 137443 Kalafungin(USAN) 0.0370731367697099 0.23060736
NSC 1390 Allopurinol 0.0370731367697099 -0.00010994331
NSC 142493 Null 0.0370731367697099 0.017675739
NSC 158263 Indoline, 5-chloro-1,3,3-trimethyl-2-methylene- (8CI) 0.0370731367697099 0.22622151
NSC 175490 Iron, carbonyl(.eta.5-2,4-cyclopentadien-1-yl)(di-4-morpholinylcarbamodithioato-S,S')- 0.0370731367697099 0.12696478
Total:159  Current:117    [First] [Prev] [Next] [Last]